Summit Partners Public Asset Management’s Exact Sciences EXAS Stock Holding History

Summit Partners Public Asset Management’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-300,000	Closed	-$15.9M	–	194
2025 Q2	$15.9M	Buy	+300,000	New	+$15.2M	0.4%	72
2019 Q4	–	Sell	-220,000	Closed	-$19.9M	–	87
2019 Q3	$19.9M	Buy	220,000 +170,000	+340%	+$19.4M	1.96%	11
2019 Q2	$5.9M	Buy	+50,000	New	+$5.04M	0.59%	65
2018 Q4	–	Sell	-150,000	Closed	-$11.8M	–	74
2018 Q3	$11.8M	Buy	+150,000	New	+$9.78M	0.8%	44

Other funds holding EXAS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Summit Partners Public Asset Management's EXAS Position: Q3 2025 in Review

Summit Partners Public Asset Management sold out of Exact Sciences (EXAS) in Q3 2025, closing a stake of 299,985 shares — an estimated $15.9M sold.

Summit Partners Public Asset Management first reported a position in EXAS in Q3 2018 and held it in 7 quarters. The position peaked at $23.2M in Q3 2018. 568 funds tracked by Wall St. Rank hold EXAS as of Q3 2025.

Summit Partners Public Asset Management reported no remaining Exact Sciences position as of Q3 2025 after selling out during the quarter.
Summit Partners Public Asset Management sold 299,985 Exact Sciences shares in Q3 2025, an estimated $15.9M.
Summit Partners Public Asset Management first reported a position in Exact Sciences in Q3 2018 and held it in 7 quarters.
Summit Partners Public Asset Management's Exact Sciences position peaked at $23.2M in Q3 2018.
568 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2025.

Based on Summit Partners Public Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.